Imeik Says Botulinum Toxin Product Not Yet on the Market

Regulation
โดย 央广财经·Read original
Summary · why it matters

Imeik stated on an interactive platform that the company's botulinum toxin product has not yet been launched for sale, and the marketing and sales team is carrying out pre-launch preparations according to the established plan.

Impact on stocks 1

Others · 1 stocks